We are live on ! Find out more
DAM

DLD Asset Management Portfolio holdings

AUM $1.1B
1-Year Est. Return 4.68%
This Fund
S&P 500
This Quarter Est. Return
+15.08%
1 Year Est. Return
+4.68%
3 Year Est. Return
+8.24%
5 Year Est. Return
+32.95%
10 Year Est. Return
–
AUM
$1.85B
AUM Growth
-$122M
Cap. Flow
-$406M
Cap. Flow %
-21.88%
Top 10 Hldgs %
74.46%
Holding
121
New
44
Increased
20
Reduced
8
Closed
32

Top Buys

Rank Stock Value
1
TECD
Tech Data Corp
TECD
+$29.6M
2
TIF
Tiffany & Co.
TIF
+$26.6M
3
LPT
Liberty Property Trust
LPT
+$17.2M
4
AGN
Allergan plc
AGN
+$16.2M
5
MDCO
Medicines Co
MDCO
+$13.3M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$44.7M
2
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$13.8M
3
CBM
Cambrex Corporation
CBM
+$7.14M
4
WBC
WABCO HOLDINGS INC.
WBC
+$7.02M
5
GWR
Genesee & Wyoming Inc.
GWR
+$6.91M

Sector Composition

Rank Sector Weight
1 Healthcare 5.9%
2 Technology 2.24%
3 Consumer Discretionary 1.32%
4 Industrials 1.16%
5 Financials 0.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
76
PUT
Acadia Pharmaceuticals
ACAD
$4.38B
– –
-38,100
Closed -$1.37M
AMRN
77
Amarin Corp
AMRN
$292M
– –
-2,500
Closed -$758K
AVTR icon
78
PUT
Avantor
AVTR
$7.56B
– –
-10,000
Closed -$147K
BIIB icon
79
CALL
Biogen
BIIB
$30.4B
– –
-303,400
Closed -$70.7M
ENTX icon
80
Entera Bio
ENTX
$97.6M
– –
-369,000
Closed -$919K
GOSS icon
81
CALL
Gossamer Bio
GOSS
$83.2M
– –
-102,000
Closed -$1.71M
GOSS icon
82
PUT
Gossamer Bio
GOSS
$83.2M
– –
-258,600
Closed -$4.34M
HHH icon
83
Howard Hughes
HHH
$4.19B
– –
-11,539
Closed -$1.43M
ILMN icon
84
Illumina
ILMN
$28.2B
– –
-7,402
Closed -$2.19M
SPR
85
DELISTED
Spirit AeroSystems
SPR
– –
-2,500
Closed -$206K
SPY icon
86
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$782B
– –
-250,000
Closed -$74.2M
SRPT icon
87
PUT
Sarepta Therapeutics
SRPT
$1.82B
– –
-31,500
Closed -$2.37M
PVLA
88
Palvella Therapeutics
PVLA
$2.26B
– –
-313
Closed -$85K
TVRD
89
PUT
Tvardi Therapeutics
TVRD
$30M
– –
-4,581
Closed -$3.01M
ITCI
90
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-202,000
Closed -$1.51M
AVTR.PRA
91
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
– –
-30,000
Closed -$1.6M
GWPH
92
PUT
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-68,000
Closed -$7.82M
FOMX
93
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-525,000
Closed -$1.6M
GWR
94
DELISTED
Genesee & Wyoming Inc.
GWR
– –
-62,516
Closed -$6.91M
PVTL
95
DELISTED
Pivotal Software, Inc.
PVTL
– –
-300,000
Closed -$4.48M
PSDO
96
DELISTED
Presidio, Inc. Common Stock
PSDO
– –
-190,000
Closed -$3.21M
ONCE
97
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-142,500
Closed -$13.8M
STI
98
DELISTED
SunTrust Banks, Inc.
STI
– –
-3,543
Closed -$244K
CBM
99
DELISTED
Cambrex Corporation
CBM
– –
-120,000
Closed -$7.14M
VIAB
100
DELISTED
Viacom Inc. Class B
VIAB
– –
-257,903
Closed -$6.2M
1 2 3
4
5

Similar funds

PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return

DLD Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, DLD Asset Management held 121 positions worth $1.85B, down 6.2% from $1.98B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

DLD Asset Management withdrew a net $406M in Q4 2019, closing 32 positions and reducing 8 holdings. Its most notable exit was Celgene Corp, an estimated $44.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 5.9% of assets, up from 5.2% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, DLD Asset Management opened a new position in Tech Data Corp worth $33M.

  • DLD Asset Management's largest Q4 2019 buy was Tech Data Corp: 230,000 shares worth $33M.
  • DLD Asset Management added most to Allergan plc in Q4 2019, an estimated $16.2M increase.
  • DLD Asset Management's biggest Q4 2019 reduction was WABCO HOLDINGS INC., cutting an estimated $7.02M.
  • DLD Asset Management fully exited Celgene Corp in Q4 2019, selling an estimated $44.7M.
  • DLD Asset Management's ten largest holdings make up 74% of its $1.85B portfolio in Q4 2019.
  • DLD Asset Management opened 44 new positions and closed 32 in Q4 2019.
  • DLD Asset Management's portfolio value fell 6.2% quarter-over-quarter to $1.85B.

Based on DLD Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.